A Multi National, Multi-center Non-interventional Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab (Actemra)
Phase of Trial: Phase IV
Latest Information Update: 09 Mar 2016
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 10 Jun 2017 Biomarkers information updated
- 07 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.